Stay updated on Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial
Sign up to get notified when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.

Latest updates to the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page
- ChecktodayChange DetectedRecruitment status on the study page now shows 'No longer looking for participants', indicating the study is no longer enrolling. The changes also add new help and navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and update the Intervention/Treatment label and revision footer to v3.6.0.SummaryDifference0.4%

- Check7 days agoChange DetectedThe page shows a minor revision update from v3.5.4 to v3.5.5. This indicates a small system update without changes to study content or user-facing information.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's revision tag was updated from Revision: v3.5.3 to Revision: v3.5.4, signaling a new build of the page. This update appears to be a minor site release and does not modify the study details or content displayed on the page.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page’s footer software/version indicator has been updated from “Revision: v3.5.2” to “Revision: v3.5.3.”SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No changes to the study details or data are visible.SummaryDifference0.1%

- Check86 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Esom/Rifampin Safety, PK and Alisertib QT Clinical Trial page.